Physician profile
Adeet Amin
NPI 1609337989
$26,585.56
in general payments reported to CMS, 2019-2025
16 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,721 · 2024: $5,540 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Grant: $10K · Travel and Lodging: $3,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,070.33 |
| Grant | $10,000.00 |
| Travel and Lodging | $3,515.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2025 | |
| Stryker Corporation | $9,603.01 | 2023-2025 | Gamma, Pro, T2 Alpha |
| Depuy Synthes Sales INC. | $3,042.79 | 2024-2025 | Na, Va-Lcp, Motoband |
| Synthes Gmbh | $1,176.97 | 2025 | |
| Medical Device Business Services, INC. | $848.07 | 2025 | Va-Lcp |
| Globus Medical, INC. | $663.17 | 2024-2025 | Anthem, A/R Femoral Nail, Distal Femur Plate System |
| Medinc of Texas | $617.13 | 2023-2025 | |
| Acera Surgical, INC. | $182.49 | 2025 | Restrata Wound Matrix |
| Pylant Medical | $156.11 | 2025 | |
| Zimmer Biomet Holdings, INC. | $125.60 | 2024-2025 | Affixus, Persona |
| Polynovo North America LLC | $58.57 | 2025 | Novosorb Btm |
| Innovation Technologies INC | $23.51 | 2025 | Irrisept |
| Heron Therapeutics, INC. | $23.22 | 2024 | Zynrelef |
| P Bar Medical LLC | $23.03 | 2025 | |
| Bioventus LLC | $22.95 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $18.94 | 2023 | I-Factor Peptide Enhanced Bone Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeet Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.